Newsletter | April 15, 2024

04.15.24 -- Navigating EU MDR Compliance: Overcoming Challenges To Sustain Your Certification

SPONSOR

Pre-Filled Syringes and Injectable Drug Devices East Coast Conference and Exhibition

The Pre-Filled Syringes and IneEast Coast Conference will return to Boston in April 2024 to bring you the latest advances in the combination product drug delivery space. The 2024 conference will be bigger and better than ever, bringing you 3 days of expertise with keynote plenaries and topic streams addressing the industry’s hottest topics through case studies and industry insights.

FEATURED EDITORIAL

Navigating EU MDR Compliance: Overcoming Challenges To Sustain Your Certification

This article dispels the myth that obtaining EU MDR certification is an end point. The evolving landscape demands ongoing diligence to comprehend and adhere to changing requirements.

INDUSTRY INSIGHTS

Placing Patients At The Center Of Drug Design

Experts discuss the best time to start thinking about patient centricity, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference.

The Use Of Injectable Packaging: Early Development To Commercialization

While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharma company sought a packaging recommendation: a stopper to maintain high-quality standards.

Imaging Large Volume Subcutaneous Injections To Inform Clinical Design

New higher volume, higher viscosity pharmaceutical formulations for subcutaneous injection, alternatives to traditional intravenous treatment, enable chronic disease therapy in alternate settings.

Overcoming Formulation Challenges For mRNA, High-Concentration Proteins

Increased demand for protein delivery and the emergence of advanced modalities – including mRNA – are introducing new challenges to the development lifecycle, such as high-concentration formulations.

SPONSOR

Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing for combination products in both the Pharma and med device industries. This two-day summit features expert insight into CP product development, and the complex quality, safety, and regulatory compliance issues facing the CP market. Pharma Ed’s Combination Products Summit 2024 provides comprehensive coverage of current and future trends in combination product development for drugs, biologics and medical devices.

SOLUTIONS

Global Experts In Nanotechnology And Drug Particle Engineering

Automatic Inspection Equipment